Syros Pharmaceuticals Inc
OTC:SYRS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Syros Pharmaceuticals Inc
OTC:SYRS
|
US |
|
K
|
Kingspan Group PLC
OTC:KGSPF
|
IE |
|
Berjaya Corporation Bhd
OTC:BRYAF
|
MY |
|
Santana Minerals Ltd
ASX:SMI
|
AU |
|
Fiserv Inc
NASDAQ:FISV
|
US |
|
Larimar Therapeutics Inc
NASDAQ:LRMR
|
US |
|
E
|
East West Banking Corp
XPHS:EW
|
PH |
|
A
|
Akzo Nobel NV
SWB:AKU1
|
NL |
|
Quess Corp Ltd
NSE:QUESS
|
IN |
|
S
|
Spearmint Resources Inc
XBER:SQH
|
CA |
|
W
|
Whitehaven Coal Ltd
XBER:WC2
|
AU |
|
M
|
Medibank Private Ltd
XMUN:MPV
|
AU |
|
S
|
S&P Global Inc
DUS:MHL
|
US |
|
Audinate Group Ltd
ASX:AD8
|
AU |
|
G
|
Green Thumb Industries Inc
XBER:R9U2
|
US |
|
Orient Green Power Company Ltd
NSE:GREENPOWER
|
IN |
|
A
|
Anaergia Inc
TSX:ANRG
|
CA |
|
NVIDIA Corp
SIX:NVDA
|
US |
|
Union Pacific Corp
NYSE:UNP
|
US |
|
Stanley Black & Decker Inc
NYSE:SWK
|
US |
|
Sona BLW Precision Forgings Ltd
NSE:SONACOMS
|
IN |
|
A
|
Abbott Laboratories
BMV:ABT
|
US |
|
V
|
Vinci SA
SWB:SQU
|
FR |
|
Dnb ASA
OTC:DNBBY
|
NO |
Bankruptcy Probability
Syros Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Syros Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Syros Pharmaceuticals Inc
NASDAQ:SYRS
|
2.7k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
382.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Syros Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Syros Pharmaceuticals Inc has total debt of 41.1m USD. This includes both short-term (0 USD) and long-term (41.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
